Pharmaceutical

The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.

There are four major factors that are impacting the value creation in pharmaceutical industry:

  • Market
    • Stress from patent expiries, niche marketing, and patient-centricity is challenging the growth plans of pharmaceutical companies. Moreover, in emerging markets, companies face strong competition from local players,who sell product at a much lower cost. To counter the same global companies need to significantly reduce their profit margins.
  • Technology
    • Rapid integration of healthcare and information technology is posing threat for current blockbuster drugs
    • Products based on new technologies offer superior properties and are more efficient as compared to existing products in the market
  • Regulation
    • There is constant price pressure from governments to meet demands of growing number of patients
    • Emerging markets have regulatory uncertainty, where decisions are made to protect the interests of the general population
    • Moreover, governments, especially in emerging economies are encouraging pharmaceutical companies to focus on preventive measures for diseases, which involves major investments
  • Innovation
    • Need for innovative products or therapies is rising constantly due to rising pressure of patent-cliff coupled with reducing profit margins
    • Identification of new bacterial and viral strains is driving the need for novel drugs

Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases

Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.

Market Challenges

The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.

Combating Challenges

Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.

Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.

Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.

Patient-centricity

Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.

Growth in Emerging Economies

The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.

Conclusion

Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.

There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.

View More

Pharmaceutical Published Insights

Coherent Market Insights Regenerative Therapies Market

Published Date : Jun 2023

Regenerative medicine is one the fastest emerging fields of medicine, as it adopts stem cells for treatment. Increasing age or injury, makes it difficult to provide the optimum amount of stem cells that are needed to maintain the normal function. The goal of regenerat... View more

Coherent Market Insights Androgen Replacement Therapy Market

Published Date : Jun 2023

Androgen substitution treatment (ART), frequently refered to as testosterone substitution treatment (TRT), is a type of chemical treatment, wherein androgens, frequently testosterone, are supplanted. In order to combat the effects of male hypogonadism, ART is frequent... View more

Coherent Market Insights Human Immunoglobulin Ph4 For Intravenous Injection Market

Published Date : Jun 2023

Human immunoglobulin for intravenous injection (IVIG) has the capacity of proving passive immunity and anti-inflammatory, immunomodulatory effect which results in better treatment and prognosis of severe infections such as COVID-19. The IgG antibodies extracted from r... View more

Coherent Market Insights Antiparasitic Drugs Market

Published Date : Jun 2023

Antiparasitic drugs are utilized to address various types of infections caused by a wide array of parasites. Parasites are small organisms that reside on or inside humans and animals. There are numerous antiparasitic drugs available, each designed to target a specific... View more

Coherent Market Insights Poultry Pharmaceuticals Market

Published Date : Jun 2023

Poultry products such as meat, chicken, eggs, and others are widely consumed globally. Demand for these products is on the rise, moreover, increasing demand for animal-based protein is a major factor, which is expected to drive growth of the poultry pharmaceuticals ma... View more

Coherent Market Insights Blood Plasma Derivatives Market

Published Date : Jun 2023

Plasma is a liquid portion of blood. About 55% of the blood is plasma, and remaining 45% are red blood cells, white blood cells, and platelets that are suspended in the plasma. Products made from human plasma using plasma fractionation techniques are known as plasma d... View more

Coherent Market Insights Health Caregiving Market

Published Date : Jun 2023

A person who gives care to people who need help taking care of themselves. Examples include children, the elderly, or patients who have chronic illnesses or are disabled. Caregivers may be health professionals, family members, friends, social workers, or members of th... View more

Coherent Market Insights Eye Health Supplements Market

Published Date : Jun 2023

Eye health is a growing concern owing to increased screen time and digital exposure. Common eye problems include eye strain, dry and red eyes, eye irritation, and watery eyes. Moreover, common eye diseases include Age-related Macular Degeneration (AMD), cataract, and ... View more

Coherent Market Insights Mena Nutraceuticals Market

Published Date : Jun 2023

Nutraceutical products are non-specific biological therapies that are used to promote general well-being, control symptoms, and to prevent malignant processes. Nutraceuticals, also called bioceuticals, are substances that are derived from food sources that exhibit phy... View more

Coherent Market Insights Meperidine Market

Published Date : Jun 2023

Pethidine or meperidine is sold under the brand name of Demerol and it is a synthetic opioid pain medication of phenylpiperidine class. Meperidine is indicated for the treatment of moderate to severe pain. It can be administered as hydrochloride salt in tablets, as a ... View more

Coherent Market Insights Diabetes Devices And Drugs Market

Published Date : Jun 2023

Diabetes devices and drugs refer to the tools and medications specifically designed to help individuals manage and treat diabetes, a chronic metabolic disorder characterized by high blood sugar levels. These devices and drugs play a crucial role in monitoring blood gl... View more

Coherent Market Insights General Medicine Education Publishing Market

Published Date : Jun 2023

General medicine, also known as internal medicine, is a specialty branch of medicine that deals with the prevention, diagnosis, and treatment of internal diseases. Commonly treated conditions with general medicine include cardio respiratory and other cardiological con... View more

Coherent Market Insights Cancer Drugs Market

Published Date : Jun 2023

Cancer is a most lethal disease in which some of the body's cells grow uncontrollably and spread to other parts of the body. Cancer drugs, such as chemotherapy, hormone therapies, targeted cancer drugs, immunotherapy drugs, and bisphosphonates, among others, are used ... View more

Coherent Market Insights Lysosomal Storage Diseases Therapeutics Market

Published Date : Jun 2023

Lysosomal storage diseases (LSDs) are diseases caused by defects in single-genes. Enzyme defects cause nearly seventy percent of the LSDs, and the rest are defects in enzyme activator or associated proteins. A gene on a particular chromosome locus transcribes a partic... View more

Coherent Market Insights Oxytocic Pharmaceuticals Market

Published Date : Jun 2023

Oxytocic drugs are administered intravenously and intramuscularly to stimulate uterine contractions during labor induction for normal child birth and control bleeding after childbirth. Administration of Oxytocic drugs help in both prevention and treatment of postpartu... View more

Coherent Market Insights North America Synthetic Opioids Market

Published Date : Jun 2023

Synthetic opioids are a class of medication that are created in labs with a specific chemical structure. The exact molecules that make up synthetic opioids are wholly man-made, generally in a pharmaceutical laboratory. Synthetic opioids are frequently pressed into pil... View more

Coherent Market Insights Animal Healthcare Market

Published Date : Jun 2023

Increasing prevalence of parasitic and infectious diseases has led to the innovations in managing animal healthcare. The most common zoonotic viral diseases diagnosed around the globe over the last few years constitute of rabies, influenza virus, Rift Valley fever, de... View more

Coherent Market Insights Europe Pharmaceutical Drugs Market

Published Date : Jun 2023

Pharmaceutical drugs are used for the treatment of chronic and acute diseases. There are two types of pharmaceutical drugs: generic and branded, which are sold through prescription and over the counter (OTC). A pharmaceutical drug that shares the same chemical compone... View more

Coherent Market Insights Anti Malarial Drugs Market

Published Date : Jun 2023

Plasmodium parasites, a protozoan parasite, are the cause of the widespread infectious disease malaria. A parasite enters the body through the bite of an infected female Anopheles mosquito, which then travels to the liver, where the parasite is produced. Human malaria... View more

Coherent Market Insights Drug And Gene Delivery Devices Market

Published Date : Jun 2023

The field of drug and gene delivery involves the development and delivery of drugs, genes, and/or gene products that ultimately alter protein expression and function of the cells, tissues, and living organisms. Drug delivery devices are the tools used to deliver the d... View more

© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.